Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain.

Cenoz MG, Martínez-Artola V, Guevara M, Ezpeleta C, Barricarte A, Castilla J.

Hum Vaccin Immunother. 2013 May;9(5):1172-6. doi: 10.4161/hv.23451. Epub 2013 Jan 16.

2.

Varicella vaccine effectiveness in the US vaccination program: a review.

Seward JF, Marin M, Vázquez M.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S82-9. doi: 10.1086/522145. Review.

PMID:
18419415
3.

Varicella vaccination in Japan: necessity of implementing a routine vaccination program.

Ozaki T.

J Infect Chemother. 2013 Apr;19(2):188-95. doi: 10.1007/s10156-013-0577-x. Epub 2013 Mar 13. Review.

PMID:
23483311
4.

Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.

Grose C.

J Clin Virol. 2005 Jun;33(2):89-95; discussion 96-8. Review.

PMID:
15911422
5.
6.

The safety profile of varicella vaccine: a 10-year review.

Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S165-9. doi: 10.1086/522125. Review.

PMID:
18419392
7.

Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.

Ozaki T.

Vaccine. 2013 Dec 9;31(51):6155-60. doi: 10.1016/j.vaccine.2013.10.060. Epub 2013 Oct 30. Review.

PMID:
24183712
8.

Global Varicella Vaccine Effectiveness: A Meta-analysis.

Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF.

Pediatrics. 2016 Mar;137(3):e20153741. doi: 10.1542/peds.2015-3741. Epub 2016 Feb 16. Review.

9.

Varicella infections and varicella vaccine in the 21st century.

Vázquez M.

Pediatr Infect Dis J. 2004 Sep;23(9):871-2. Review. No abstract available.

PMID:
15361729
11.

Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.

Watson B.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S143-6. doi: 10.1086/522130. Review.

PMID:
18419388
12.

Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Bonanni P, Gershon A, Gershon M, Kulcsár A, Papaevangelou V, Rentier B, Sadzot-Delvaux C, Usonis V, Vesikari T, Weil-Olivier C, de Winter P, Wutzler P.

Pediatr Infect Dis J. 2013 Jul;32(7):e305-13. doi: 10.1097/INF.0b013e31828b7def. Review.

13.

Varicella prevention in the United States: a review of successes and challenges.

Marin M, Meissner HC, Seward JF.

Pediatrics. 2008 Sep;122(3):e744-51. doi: 10.1542/peds.2008-0567. Review.

PMID:
18762511
14.

The vaccine against varicella: do we have the optimal vaccine?

Granström M.

Pediatr Infect Dis J. 2014 Oct;33(10):1083-4. doi: 10.1097/INF.0000000000000488. Review. No abstract available.

PMID:
25093978
15.

Should the UK introduce varicella vaccine?

Roderick M, Ramanan AV, Finn A.

Arch Dis Child. 2007 Dec;92(12):1051-2. Epub 2007 Nov 8. Review. No abstract available.

16.

Systematic Review of Effectiveness of Varicella Vaccines: A Critical Appraisal: Evidence based Medicine Viewpoint.

Mathew JL.

Indian Pediatr. 2016 May 8;53(5):418-20. Review. No abstract available.

17.

Varicella after the perinatal period.

Berkoff MC, Brown WD.

Pediatr Rev. 2013 Nov;34(11):537-8. doi: 10.1542/pir.34-11-537. Review. No abstract available.

PMID:
24187146

Supplemental Content

Support Center